|
|
| November 17, 2004: Interventional Cardiology: Past, Present, Future |
This video is sponsored by the Duke Clinical Medical Series.
Peter Berger, MD and David Holmes, Jr., MD have indicated that all devices discussed in
this presentation are off-label, experimental and/or investigational. The moderator, Peter
Berger, MD, has indicated that he receives research/grant support from Aventis, Conor,
Guilford, Lumen, and Velocimed. Dr. Berger is also a member of an advisory board for
Genentech and Cordis/Johnson & Johnson; he has spoken at scientific symposia for
Aventis, Bristol-Myers Squibb, Genentech, and Guilford. Dr. Berger also serves as Medical
Director and has equity with Lumen, Inc.
The guest, David R. Holmes, MD, has nothing to disclose relative to this CME activity.
|
| |